Interplay between sympathetic nervous system and inflammation in aseptic loosening of hip joint replacement

[1]  Brian T. Maurer.  Regression. , 2020, JAAPA : official journal of the American Academy of Physician Assistants.

[2]  M. Lamghari,et al.  Neuroimmune expression in hip osteoarthritis: a systematic review , 2017, BMC Musculoskeletal Disorders.

[3]  I. Elenkov,et al.  Neuropeptide Y as regulator of macrophage phenotype and functions: a neuroimmune CUE in atherosclerosis regression? , 2017, Atherosclerosis.

[4]  M. Schellings,et al.  Sema3A promotes the resolution of cardiac inflammation after myocardial infarction , 2017, Basic Research in Cardiology.

[5]  M. Lamghari,et al.  Immune response and innervation signatures in aseptic hip implant loosening , 2016, Journal of Translational Medicine.

[6]  N. Athanasou,et al.  The pathobiology and pathology of aseptic implant failure , 2016, Bone & joint research.

[7]  P. Wooley,et al.  Macrophage Polarization in IL-10 Treatment of Particle-Induced Inflammation and Osteolysis. , 2016, The American journal of pathology.

[8]  Marco Cosentino,et al.  Adrenergic regulation of innate immunity: a review , 2015, Front. Pharmacol..

[9]  M. Mareel,et al.  Matrix metalloproteases as maestros for the dual role of LPS- and IL-10-stimulated macrophages in cancer cell behaviour , 2015, BMC Cancer.

[10]  Y. Saeki,et al.  Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications , 2015, Arthritis & rheumatology.

[11]  Y. Goshima,et al.  Semaphorin 3A controls allergic and inflammatory responses in experimental allergic conjunctivitis. , 2015, International journal of ophthalmology.

[12]  R. Straub,et al.  The sympathetic nervous response in inflammation , 2014, Arthritis Research & Therapy.

[13]  Fan Yang,et al.  Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement , 2014, Journal of The Royal Society Interface.

[14]  J. V. Sarma,et al.  Induction of M2 Regulatory Macrophages through the β2-Adrenergic Receptor with Protection during Endotoxemia and Acute Lung Injury , 2014, Journal of Innate Immunity.

[15]  S. Goodman,et al.  Role of macrophages in the biological reaction to wear debris from joint replacements. , 2014, Journal of long-term effects of medical implants.

[16]  S. Goodman,et al.  Macrophage polarization in response to wear particles in vitro , 2013, Cellular and Molecular Immunology.

[17]  H. Schaible,et al.  The innervation of synovium of human osteoarthritic joints in comparison with normal rat and sheep synovium. , 2013, Osteoarthritis and cartilage.

[18]  Y. Goshima,et al.  Decreased Semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis , 2013, BMC Musculoskeletal Disorders.

[19]  S. Goodman,et al.  Revision joint replacement, wear particles, and macrophage polarization. , 2012, Acta biomaterialia.

[20]  V. Sanders.  The beta2-adrenergic receptor on T and B lymphocytes: Do we understand it yet? , 2012, Brain, Behavior, and Immunity.

[21]  M. Dimitrijević,et al.  The intriguing mission of neuropeptide Y in the immune system , 2011, Amino Acids.

[22]  D. Perez,et al.  Modulation of immune cell function by α(1)-adrenergic receptor activation. , 2011, Current topics in membranes.

[23]  A. Catalano.  The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis , 2010, The Journal of Immunology.

[24]  Š. Podzimek,et al.  Influence of metals on cytokines production in connection with successful implantation therapy in dentistry. , 2010, Neuro endocrinology letters.

[25]  W. Falk,et al.  Soluble neuropilin-2, a nerve repellent receptor, is increased in rheumatoid arthritis synovium and aggravates sympathetic fiber repulsion and arthritis. , 2009, Arthritis and rheumatism.

[26]  A. Major,et al.  Differences in the injury/sprouting response of splenic noradrenergic nerves in Lewis rats with adjuvant-induced arthritis compared with rats treated with 6-hydroxydopamine , 2009, Brain, Behavior, and Immunity.

[27]  C. Jiang,et al.  Neuropeptide Y promotes TGF-β1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor , 2008, Neuroscience Bulletin.

[28]  W. Falk,et al.  Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation , 2008, Gut.

[29]  Herbert Herzog,et al.  NPY and receptors in immune and inflammatory diseases. , 2007, Current topics in medicinal chemistry.

[30]  D. Nance,et al.  Autonomic innervation and regulation of the immune system (1987–2007) , 2007, Brain, Behavior, and Immunity.

[31]  J. Clohisy,et al.  Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies , 2007, Arthritis research & therapy.

[32]  J. Schölmerich,et al.  Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems , 2005, Annals of the rheumatic diseases.

[33]  M. Puerto,et al.  Modulation of neuropeptide Y and norepinephrine on several leucocyte functions in adult, old and very old mice , 2005, Journal of Neuroimmunology.

[34]  P. Ernfors,et al.  Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[35]  R. Straub,et al.  Sympathetic neurotransmitters in joint inflammation. , 2005, Rheumatic diseases clinics of North America.

[36]  A. Beck‐Sickinger,et al.  Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors , 2005, Regulatory Peptides.

[37]  R. Geenen,et al.  Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. , 2004, Clinical and experimental rheumatology.

[38]  D. Bellinger,et al.  Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases. , 2003, Current drug targets. Inflammation and allergy.

[39]  J. Schölmerich,et al.  Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. , 2002, Arthritis and rheumatism.

[40]  D. Moura,et al.  Vascular adrenoceptors: an update. , 2001, Pharmacological reviews.

[41]  R. Straub,et al.  Involvement of the hypothalamic--pituitary--adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. , 2001, Arthritis and rheumatism.

[42]  R. Straub,et al.  The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  H. Raspe,et al.  Knee replacement surgery for osteoarthritis: effectiveness, practice variations, indications and possible determinants of utilization. , 1999, Rheumatology.

[44]  C. Ranawat,et al.  Indications for total hip and total knee arthroplasties. Results of orthopaedic surveys. , 1996, The Journal of arthroplasty.

[45]  P. Mapp.  Innervation of the synovium. , 1995, Annals of the rheumatic diseases.